Chimeric Antigen Receptor Engineered Human Gamma Delta T Cells; Enhanced Cytotoxicity With Retention of Cross Presentation
Molecular Therapy - United States
doi 10.1016/j.ymthe.2017.12.001
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2018
Authors
Publisher
Elsevier BV